Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells

mBio(2021)10.1128/mbio.02243-21Source: DataRank Database

The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells is a research paper published in mBio (2021). On theSindex it has a DataRank of 0. It has been cited 47 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access47 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 2.19)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Adityarup Chakravorty,Mitch Hayes,Wolfgang Hammerschmidt ORCID,Bill Sugden ORCID,Danielle Westhoff Smith

Live enrichment

PubMed:34781735 PMC:PMC8593684 OpenAlex:https://openalex.org/W3213772518

HHS | NIH | National Cancer Institute

Grant: P01 CA022443

HHS | NIH | National Cancer Institute

Grant: R01 CA133027

HHS | NIH | National Cancer Institute

Grant: R01 CA070723

HHS | National Institutes of Health

Grant: T32 CA009135

NCI NIH HHS

Grant: P30 CA015704

NCI NIH HHS

Grant: P30 CA014520

National Institutes of Health

Grant: 2R01CA070723-16A1

Genetic Analysis of EBV's Immortalizing Genes

National Institutes of Health

Grant: 3P01CA022443-43S1

Developing and Applying a Safe, Tractable Derivative of SARS-CoV-2

National Institutes of Health

Grant: 3T32CA009135-13S1

PREDOCTORAL TRAINING IN EXPERIMENTAL ONCOLOGY

National Institutes of Health

Grant: 5R01CA133027-02

EBV's Plasmid Replicon: Its Synthesis, Partitioning, and Maintenance of Tumors

National Institutes of Health

Grant: 5P30CA014520-18

CANCER CENTER SUPPORT

FWCI

2.19

Citation Percentile

0.9%

Influential Citations

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.02243-21

GOLDhttps://doi.org/10.1128/mbio.02243-21

publisherhttps://doi.org/10.1128/mbio.02243-21

publisherhttps://journals.asm.org/doi/pdf/10.1128/mBio.02243-21

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34781735

Fields of Study

Viral-associated cancers and disordersHead and Neck Cancer StudiesHerpesvirus Infections and TreatmentsMedicineBiology0301 basic medicine03 medical and health sciences

MeSH Terms

Memory B CellsCell LineHerpesvirus 4, HumanHumansKiller Cells, NaturalApoptosisEpstein-Barr Virus Nuclear AntigensEpstein-Barr Virus InfectionsIntracellular Signaling Peptides and ProteinsHost-Pathogen InteractionsGPI-Linked Proteins

Keywords

Immune systemInnate immune systemNKG2DVirusAcquired immune systemInnate lymphoid cellImmunityNK-92B cellEpstein-Barr virusc-mycNatural killer cellsinnate immunityHerpesvirusesUlbpEpstein-Barr Virus InfectionsHerpesvirus 4, HumanIntracellular Signaling Peptides and ProteinsApoptosisGPI-Linked ProteinsMicrobiologyB Cell ; Epstein-barr Virus ; Ulbp ; C-myc ; Herpesviruses ; Innate Immunity ; Natural Killer CellsQR1-502Cell LineKiller Cells, NaturalEpstein-Barr Virus Nuclear AntigensMemory B CellsHost-Pathogen InteractionsHumansResearch Article

Sustainable Development Goals

SDG 3: 3. Good health